Antibiotics in critically ill dogs: What the ampicillin/sulbactam study means for treatment

A seriously ill dog often requires rapid and intensive treatment. If a bacterial infection is suspected, antibiotics can play a crucial role in this treatment. However, it's not simply a matter of administering any antibiotic as early as possible. The key factors are whether the chosen medication reaches the suspected pathogen, whether that pathogen is susceptible, and whether sufficiently high concentrations of the active ingredient are achieved in the patient's body.

A study published in 2025 on the intravenous administration of ampicillin/sulbactam in critically ill dogs demonstrates how differently an antibiotic can behave in critically ill patients. The study provides important insights into why Antibiotics in the critically ill dog They must be individually selected and repeatedly checked throughout the course of treatment.

This article is aimed at pet owners and explains the results from a veterinary perspective. It does not replace an examination or an individual treatment decision. A critically ill dog always requires the immediate care of a veterinarian or a suitably equipped veterinary clinic.

Antibiotics for critically ill dogs must be appropriate for the pathogen, organ, and patient.

Treating critically ill dogs is among the most demanding tasks in small animal medicine. In my many years of clinical experience, I have repeatedly witnessed how the condition of such patients can change dramatically within just a few hours. Circulation, kidney function, fluid balance, blood flow, and organ function can fluctuate significantly. These changes also directly affect how medications are distributed and eliminated from the body.

Therefore Antibiotics in a critically ill dog This is not comparable to a routine administration of tablets for an uncomplicated infection. The veterinarian must answer several questions simultaneously:

• Is there actually a bacterial infection?
• Which pathogen is likely involved?
• Where is the infection located?
• Does the active ingredient reach this site of infection?
• Are the liver and kidneys functioning adequately?
• Are there already indications of resistant bacteria?
• Is a combination of several active ingredients necessary?
• Can samples be obtained for bacteriological examination?

An antibiotic can be effective against a specific type of bacteria and still fail in an individual patient. This can happen, for example, if the concentration of the active ingredient at the site of infection is not high enough or does not remain above the necessary threshold of effectiveness for long enough.

Why serious illnesses can change the effectiveness of antibiotics

In a healthy dog or one with only mild illness, the way many medications are processed can be predicted relatively well. In an intensive care patient, the situation is often much more complicated. Severe inflammation can increase the permeability of blood vessels, leading to increased fluid leakage into the tissues. At the same time, many patients receive intravenous fluids to stabilize their circulation.

This can change the volume of distribution of a water-soluble antibiotic. Put simply, the same amount of the active ingredient may be distributed over a larger volume of fluid. As a result, the concentration in the blood may be lower than expected.

Excretion can also change. Some critically ill dogs develop impaired kidney function and excrete certain antibiotics more slowly. In other patients, renal blood flow is temporarily increased, allowing medications to be excreted more quickly. Additional changes can occur in protein binding, blood pressure, tissue perfusion, and acid-base balance.

These factors explain why Antibiotics in a critically ill dog Despite standardized dosing, highly variable drug levels can be produced. The underlying study on ampicillin/sulbactam also observed a pronounced variability in the measured ampicillin concentrations. No clear patient characteristics were found that could reliably predict these differences. However, the study only included 25 dogs and was not designed to definitively determine all possible influencing factors.

What is ampicillin/sulbactam?

Ampicillin belongs to the beta-lactam antibiotics. The active ingredient inhibits the formation of the bacterial cell wall. As a result, susceptible bacteria can no longer multiply properly and are damaged.

Sulbactam is a so-called beta-lactamase inhibitor. Some bacteria produce enzymes that can break down certain beta-lactam antibiotics, rendering them ineffective. Sulbactam blocks some of these enzymes and can therefore broaden the spectrum of activity of ampicillin.

However, this does not mean that ampicillin/sulbactam is automatically effective against all bacteria. Bacteria can have different resistance mechanisms. Some produce enzymes that are not sufficiently inhibited by sulbactam. Others alter their binding sites, reduce the uptake of the antibiotic, or actively transport it out of the cell.

When selecting Antibiotics in a critically ill dog The term "broad-spectrum antibiotic" should therefore not be understood as a guarantee of comprehensive effectiveness. A broader spectrum of activity simply means that a drug can be effective against several groups of bacteria. It does not mean that every individual pathogen is susceptible.

What was investigated in the study?

In this prospective observational study, 25 severely ill dogs received intravenous ampicillin/sulbactam. The total dose was 30 milligrams per kilogram of body weight, divided into 20 milligrams of ampicillin and 10 milligrams of sulbactam per kilogram. The doses were administered eight hours apart.

Blood samples were taken before administration and at several predetermined time points within the subsequent eight-hour dosing interval. The researchers then determined the plasma concentrations of the active substances and evaluated their pharmacokinetic profile.

For beta-lactam antibiotics, the crucial factor is how long the concentration of the free, non-protein-bound drug remains above the minimum inhibitory concentration (MIC) of the pathogen. The researchers set a target of ensuring that the free ampicillin concentration should remain above the MIC for at least 50 percent of the dosing interval.

The study therefore focused on the probability of achieving a pharmacological target value. It was not a clinical comparative study examining cure or survival rates of different antibiotic therapies. Consequently, the results do not allow us to conclude that a particular treatment regimen will necessarily be successful or unsuccessful for every patient.

What does "time above the MIC" mean?

The minimum inhibitory concentration (MIC) is the lowest concentration of an antibiotic at which the visible growth of a specific bacterium is inhibited under standardized laboratory conditions. The higher the MIC of a pathogen, the more of the drug is generally required to control bacterial growth.

With ampicillin and other beta-lactam antibiotics, the maximum concentration alone is not the deciding factor. More important is that the concentration remains above the MIC for a sufficiently long period. A very high peak that then drops rapidly can therefore be less beneficial than a sustained, sufficiently high concentration.

For Antibiotics in a critically ill dog This relationship is particularly important. If a serious illness alters the distribution or excretion of the medication, the drug level can fall below the necessary threshold sooner than expected. Conversely, impaired excretion can lead to a longer drug duration.

MIC is determined through culture and susceptibility testing or classified using standardized breakpoints. When interpreting results, species-specific and site-specific breakpoints should be used whenever possible. The Clinical and Laboratory Standards Institute provides veterinary standards for this purpose. The seventh edition of Supplement VET01S was published in January 2024 and contains updated tables for veterinary susceptibility testing.

Key findings on ampicillin/sulbactam

Plasma concentrations of ampicillin varied considerably between the dogs studied. Although all patients were treated according to the same weight-based regimen, no uniform concentration profiles were observed.

At a very low MIC of 0.25 micrograms per milliliter, the investigated dosage most likely achieved the desired pharmacological target value. This value corresponds to a dog-specific cutoff value described by the CLSI for certain skin and soft tissue infections.

With a significantly higher threshold of 8 micrograms per milliliter, the probability of reaching the target value was only about ten percent, according to the published analysis. Many gram-negative Enterobacterales, including numerous strains of Escherichia coli and Klebsiella pneumoniae, are not sensitive to low ampicillin concentrations.

The results therefore argue against considering ampicillin/sulbactam as the sole empirical treatment for suspected severe gram-negative infections outside the lower urinary tract. However, they do not prove that the drug is ineffective in every patient or at every site of infection. The specific pathogen, its minimally invasive size (MIS), the site of infection, and the individual concentration profile remain crucial factors.

Why E. coli and Klebsiella are particularly relevant

Escherichia coli It is part of the normal intestinal flora, but under unfavorable circumstances it can cause serious infections. These include urinary tract infections, peritonitis following intestinal injury, wound infections, and bacterial blood infections.

Also Klebsiella pneumoniae It can cause opportunistic infections and some strains exhibit pronounced resistance mechanisms. In severely ill or previously treated patients, the risk of resistant pathogens is generally higher than in uncomplicated primary infections.

Therefore, Antibiotics in a critically ill dog The goal is to be effective against the most likely pathogens without using an unnecessarily large number of active ingredients. This is a difficult balancing act. An initial therapy that is too narrow may miss a dangerous pathogen. Conversely, an unnecessarily broad or excessively long therapy increases the selective pressure and can promote the development and spread of resistant bacteria.

A study on prescribing practices in veterinary emergency and intensive care medicine indicates that resistant pathogens complicate empirical antibiotic selection. The authors therefore emphasize the importance of structured antimicrobial stewardship measures. These include well-founded indication, appropriate sample collection, therapy review, and adjustment based on laboratory results.

Why the site of infection affects effectiveness

A laboratory result cannot be interpreted in isolation from the site of infection. Antibiotics do not reach the same concentration in every organ. For certain drugs, significantly higher concentrations can occur in urine than in blood or tissue. Therefore, an antibiotic may still be effective in a lower urinary tract infection, even though the concentrations reached in the blood would be insufficient for an infection in another organ.

Treatment requirements differ between pneumonia, peritonitis, deep wound infections, and bacterial bloodstream infections, and between uncomplicated bladder infections and pneumonia. The blood supply to the affected tissue, the presence of necrotic tissue, foreign material, pus accumulation, or biofilms also influence treatment success.

With Antibiotics in a critically ill dog Therefore, controlling the source of infection is part of the treatment. An abscess may need to be opened and drained. Necrotic tissue may need to be surgically removed. Septic peritonitis often requires surgery. Antibiotics cannot replace necessary surgical intervention.

Why a culture before administering antibiotics is so valuable

In a stable patient, it is often possible to take specific material for a bacterial culture before starting treatment. However, in a critically ill dog, necessary therapy must not be irresponsibly delayed.

In intensive care medicine, the goal is therefore to obtain suitable samples as early as possible and then treat them quickly. Depending on the illness, blood cultures, urine, fluid from body cavities, wound material, joint fluid, or tissue samples can be examined.

The laboratory first attempts to culture the pathogen. Then, it tests which antibiotics the isolated germ is susceptible or resistant to. This result is called an antibiogram.

For Antibiotics in a critically ill dog The antibiogram is particularly important because the initial treatment is often empirical. Empirical means that the veterinarian selects an initial therapy based on the suspected site of infection, typical pathogens, local resistance data, and the patient's condition before the final laboratory results are available.

Once the results are available, the treatment should be reviewed. If the pathogen is susceptible, the therapy can be confirmed or specifically reduced. If it is resistant, the regimen must be adjusted. If no relevant bacterial pathogen is detected and the other findings also argue against a bacterial infection, discontinuation of the treatment may be considered.

Dog-specific limit values instead of uncritical transfer

Not every combination of bacterium, antibiotic, animal species, and site of infection has its own veterinary threshold value. In such cases, laboratories sometimes resort to other scientifically based interpretations. However, human medical threshold values cannot automatically be applied to dogs.

Dosages, drug distribution, excretion, and achievable concentrations at the site of infection can differ between humans and dogs. Usual administration intervals also vary.

The study therefore underlines that laboratories for Antibiotics in a critically ill dog Veterinarians should use dog-specific threshold values whenever possible. Furthermore, a finding should not be interpreted solely based on the label "sensitive" or "resistant." The veterinarian must consider the result in relation to the site of infection, the chosen dosage regimen, and the patient's overall condition.

Is a combination of several antibiotics necessary?

If a critically ill dog is strongly suspected of having a severe infection with gram-negative bacteria, ampicillin/sulbactam alone may not offer sufficient empirical efficacy. Therefore, in certain situations, it is combined with another active ingredient that has better activity against gram-negative aerobic bacteria.

The published classification mentions fluoroquinolones and aminoglycosides as possible combination partners. However, this is not a general recommendation to treat every seriously ill dog with multiple antibiotics.

Fluoroquinolones are among the most important active ingredients and should be used judiciously. Aminoglycosides can damage the kidneys, among other things, and are only suitable for patients with circulatory problems, dehydration, or impaired kidney function after careful consideration.

Furthermore, combining medications does not automatically increase efficacy. It can increase side effects, interactions, costs, and selection pressure. Therefore, combinations must be carefully considered. Antibiotics in a critically ill dog medically justified, regularly reviewed and adjusted based on the antibiogram where possible.

What role does kidney function play?

Ampicillin is largely excreted via the kidneys. Therefore, in dogs with impaired kidney function, the drug can remain in the body for a longer period. Previous studies have shown a longer half-life and higher drug exposure in azotemic dogs compared to healthy control animals.

Another study with hospitalized azotemic and non-azotemic dogs also found significant differences. Renal function can therefore be an important influencing factor. Nevertheless, a single creatinine value cannot accurately predict the ampicillin concentration that will develop in every critically ill patient.

With Antibiotics in a critically ill dog Therefore, kidney function, urine output, fluid balance, and clinical course are frequently monitored. Depending on the active ingredient, adjustments to the dosing interval or dose may be necessary. Such changes must only be made by the attending veterinarian.

Continuous or more frequent administration

Because beta-lactam antibiotics have a time-dependent effect, different administration strategies are being investigated in intensive care medicine. In addition to single injections at fixed intervals, prolonged or continuous infusions are being considered.

A small study of eleven dogs with septic peritonitis compared continuous with intermittent ampicillin/sulbactam infusion. The results support the hypothesis that continuous administration may prolong the time above the minimally invasive threshold (MIC) in certain patients. However, the authors emphasized that further clinical trials are needed before optimal dosages and actual treatment outcomes can be definitively assessed.

Continuous infusion is not automatically the best solution for every patient. It requires suitable infusion tubing, guaranteed stability of the medication, and careful management of other intravenous drugs. Potential incompatibilities from administering different solutions simultaneously must also be considered.

Ampicillin/Sulbactam as surgical prophylaxis

Antibiotic prophylaxis before surgery pursues a different goal than the treatment of an existing infection. The active ingredient should be present in sufficient concentration in the tissue at the time of the skin incision and during the period of potential bacterial contamination.

A population pharmacokinetic meta-analysis of five beta-lactam antibiotics investigated suitable dosing regimens for surgical prophylaxis in dogs. For ampicillin, the analysis clearly showed that the correct timing of administration before the procedure and a second dose for longer surgeries can be crucial.

The timeframes mentioned in the discussed summary should not be interpreted as instructions for pet owners. Planning, selection, timing, and repetition of perioperative antibiotic administration are the sole responsibility of the surgical team.

The same applies to surgery: Antibiotics in a critically ill dog They do not replace careful sterile working practices, good tissue treatment, and professional control of a contamination source.

How can the owner recognize a serious deterioration?

A critically ill dog is usually already under veterinary care. Nevertheless, it's important to be aware of early warning signs. Possible warning signs include:

• severe apathy or disturbances of consciousness,
• very rapid or labored breathing,
• pale, grey or bluish mucous membranes,
• repeated vomiting or bloody diarrhea,
• a severely bloated or painful abdomen,
• Circulatory weakness or collapse,
• significantly reduced urine production,
• very high or unusually low body temperature,
• significantly accelerated or unusually slow heartbeat,
• A rapid deterioration following surgery or injury.

If such symptoms occur, a veterinary practice or animal hospital should be contacted immediately. It is dangerous to administer antibiotics at home without consulting a veterinarian. Incorrect medications, unsuitable dosages, or treatments that are too short can mask the course of the illness, cause side effects, and complicate subsequent pathogen identification.

What does the study mean for pet owners?

This study does not mean that ampicillin/sulbactam is a bad antibiotic. The drug can be valuable when appropriately indicated. Rather, the study shows that its use in severely ill dogs must be considered carefully.

The following points are particularly important for pet owners:

Antibiotics in a critically ill dog Drugs are selected based on the suspected pathogen and site of infection. A bacterial culture can significantly refine the treatment. The patient's condition can alter the required drug concentrations. A broad spectrum of activity does not guarantee efficacy against every pathogen. Combination therapy is only advisable in specific situations. The treatment plan must be reviewed after the laboratory results are available.

In my view, transparent communication is particularly important. Pet owners should know why samples are being taken, why several medications might be necessary initially, and why the treatment regimen may need to be changed after a few days. An adjustment doesn't mean the initial decision was wrong. It's often a sign that new information is being used responsibly.

Frequently asked questions about antibiotics for seriously ill dogs

Detailed summary

Antibiotics in a critically ill dog They can be lifesaving in cases of severe bacterial infection. At the same time, they require Antibiotics in a critically ill dog A particularly careful selection is required because the absorption, distribution, and excretion of medications can change significantly in intensive care patients.

Antibiotics in a critically ill dog Antibiotics should not be selected solely based on the label "broad-spectrum antibiotic." Even a broad-spectrum drug will not reach every pathogen, every organ, or every patient in a sufficient concentration.

The new study on ampicillin/sulbactam shows that Antibiotics in a critically ill dog Despite the same weight-based dosage, very different plasma concentrations can be produced. This variability makes it clear why standardized dosage tables alone do not cover every clinical situation.

Ampicillin belongs to the time-dependent beta-lactam antibiotics. Antibiotics in a critically ill dog It is therefore important that the free drug concentration remains above the minimum inhibitory concentration of the pathogen for a sufficiently long time.

The minimum inhibitory concentration describes the concentration required in the laboratory to inhibit the growth of a specific bacterium. Antibiotics in a critically ill dog This laboratory value must be correlated with the concentrations actually achievable in the body.

The study with 25 severely ill dogs showed that the desired pharmacological target value was likely achieved with a low MIC. This was significantly less common with higher MIC values. Antibiotics in a critically ill dog Therefore, they cannot be assessed independently of the sensitivity of the pathogen.

Special caution is required in cases of suspected infections with gram-negative Enterobacterales. Antibiotics in a critically ill dog must be aware of potential pathogens such as E. coli or Klebsiella pneumoniae possess a sufficiently reliable spectrum of activity.

Ampicillin/sulbactam can be effective against certain susceptible pathogens. However, it may be insufficient as the sole empirical treatment for severe gram-negative infections outside the lower urinary tract. Antibiotics in a critically ill dog They must therefore be adapted to the suspected location of infection.

The site of infection influences the achievable concentration. Higher concentrations can occur in urine than in blood or certain tissues. Antibiotics in a critically ill dog Therefore, a laboratory limit value must not be interpreted without taking into account the organ affected.

A bacterial culture and an antibiogram are among the most important tools for targeted therapy. Antibiotics in a critically ill dog Tests are often started before the final laboratory results are available. However, suitable samples should ideally be obtained before the first dose.

The treatment must be reviewed after the antibiogram results are received. Antibiotics in a critically ill dog Antibiotic therapy can then be confirmed, changed, reduced, or discontinued in justified cases. Such adjustments are an important component of responsible antibiotic therapy.

When interpreting results, dog-specific threshold values should be used whenever possible. Human medical values cannot be automatically applied. Antibiotics in a critically ill dog They are used in different dosages and intervals than corresponding preparations in humans.

In some emergency situations, a combination of several active ingredients is required. Antibiotics in a critically ill dog Initially, it may be necessary to cover a broader spectrum if the pathogen is not yet known and a delay would be life-threatening.

However, a combination is not automatically better. More Antibiotics in a critically ill dog They can cause more side effects, interactions, and selective pressure. Therefore, every combination must be medically justified and reassessed after new findings become available.

Fluoroquinolones are effective against various gram-negative bacteria, but should be used selectively. Aminoglycosides can also be effective, but pose a significant risk to the kidneys. Antibiotics in a critically ill dog They must therefore always be considered in relation to the individual risk of side effects.

Kidney function plays a special role. If a drug is primarily excreted via the kidneys, impaired kidney function can lead to higher and longer-lasting concentrations. Antibiotics in a critically ill dog Therefore, frequent repeated checks of kidney function and urine production are often necessary.

Even kidney function that initially appears normal can change during a critical illness. Antibiotics in a critically ill dog Therefore, it is not sufficient to consider only a single laboratory value at the beginning of treatment.

In addition to the choice of active ingredient, the method of administration is relevant. For time-dependent active ingredients... Antibiotics in a critically ill dog More frequent, prolonged, or continuous infusions may offer pharmacological benefits in certain cases. However, whether this results in a better clinical outcome must be assessed for each specific situation.

A small study in dogs with septic peritonitis suggests that continuous ampicillin/sulbactam infusion may prolong the time above certain MIC values. However, this should not be interpreted as a general recommendation for all dogs. Antibiotics in a critically ill dog can be derived.

Antibiotics cannot replace necessary control of the source of infection. In the case of an abscess, intestinal injury, necrotic tissue, or infected foreign material, antibiotics are insufficient. Antibiotics in a critically ill dog alone might not be enough.

Surgery, irrigation, drainage, or removal of damaged tissue can be crucial. Only the combination of controlling the source of infection, intensive care stabilization, and appropriate treatment will ensure a successful outcome. Antibiotics in a critically ill dog In many cases, this creates the conditions for successful treatment.

Pet owners should understand that a change in therapy does not necessarily indicate a treatment error. Antibiotics in a critically ill dog Initially, they are often selected based on the most likely pathogens and later refined through specific laboratory information.

Similarly, a higher dose does not automatically mean a better effect. Antibiotics in a critically ill dog Efficacy and tolerability must be considered together. An inappropriate dose increase can cause side effects without resolving an existing resistance problem.

Residues from previous antibiotic treatments should never be administered independently. Unsuitable Antibiotics in a critically ill dog They can alter symptoms, complicate cultivation, and cost valuable time until the correct treatment is found.

Premature discontinuation or independent extension is also problematic. The duration of Antibiotics in a critically ill dog depends on the site of infection, the pathogen, the course of the infection, and the successful control of the cause.

The study on ampicillin/sulbactam does not provide a ready-made dosage guide for every intensive care patient. Rather, it shows that Antibiotics in a critically ill dog require an individual pharmacological and clinical assessment.

From a veterinary perspective, the most important message is that Antibiotics in a critically ill dog These measures should not be used reflexively or hesitantly. In cases of well-founded suspicion of a serious bacterial infection, rapid action is necessary. At the same time, samples, the likelihood of pathogen identification, organ function, and resistance risks must be taken into account.

Responsible treatment combines rapid emergency medicine with targeted diagnostics. In this way, Antibiotics in a critically ill dog effectively used and unnecessary burdens avoided.

For pet owners, this means: questions about sample collection, the suspected pathogen, the antibiogram, and necessary follow-up examinations are expressly recommended. The more transparent the medical decisions are, the more understandable the reasons become. Antibiotics in a critically ill dog can be adjusted during treatment.

Ultimately, the strongest or broadest-spectrum preparation is not automatically the best. Successful Antibiotics in a critically ill dog These are the active ingredients that match the pathogen, the site of infection, the sensitivity, and the current organ function of the individual patient.

Technical classification

This article was written and professionally classified from the veterinary perspective of Susanne Arndt.

Susanne Arndt is a veterinarian, medical director, and owner of small animal practices in Karlsbad-Ittersbach and Karlsbad-Langensteinbach. She studied at the Faculty of Veterinary Medicine at the University of Leipzig. Following her studies, she worked for six years as an assistant veterinarian at the Dr. Thomas Graf Small Animal Clinic in Cologne and spent a year developing and expanding the small animal department at the Lahr Animal Health Center. She has owned the small animal practices in Karlsbad since 2013.

Her further education includes a Master of Small Animal Science degree from the Free University of Berlin and ongoing training in the field of osteosynthesis. She is a member of the German Veterinary Medical Society, the Feline Medicine Working Group of the German Society for Veterinary Medicine and the Laser Medicine Working Group of the German Society for Veterinary Medicine and the German Veterinary Association.

International specialist sources and further reading

Intravenous Ampicillin/Sulbactam in Critically Ill Dogs Has Variable Pharmacokinetics, Journal of Veterinary Pharmacology and Therapeutics

Antimicrobial Prescribing Practices in Small Animal Emergency and Critical Care, Frontiers in Veterinary Science

Pharmacokinetics of Ampicillin-Sulbactam in Azotemic and Non-Azotemic Dogs

Ampicillin Pharmacokinetics in Azotemic and Healthy Dogs

Comparison of Continuous and Intermittent Ampicillin-Sulbactam Infusions in Dogs With Septic Peritonitis

Population Pharmacokinetic Meta-Analysis of Beta-Lactam Antibiotics for Surgical Prophylaxis in Dogs

CLSI VET01S – Veterinary Antimicrobial Susceptibility Testing Standards